Welcome to our dedicated page for Cimpress Plc SEC filings (Ticker: CMPR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Cimpress plc (NASDAQ: CMPR), an Ireland-based print mass-customization company in the commercial printing and manufacturing sector. Cimpress files periodic and current reports, proxy statements and other documents that describe its financial condition, governance and shareholder matters.
Among the key filings for CMPR are annual reports on Form 10-K, which include audited financial statements and detailed discussion of Cimpress’ print mass-customization businesses and brands such as VistaPrint, WIRmachenDRUCK, Pixartprinting, Pens.com, BuildASign, druck.at, Drukwerkdeal, easyflyer, Exaprint, Packstyle, Printi, Tradeprint, BoxUp and National Pen. Quarterly results and related information are often furnished via Form 8-K, where Cimpress has reported the posting of its quarterly earnings documents for fiscal year 2025 and fiscal year 2026 periods.
Cimpress also files a definitive proxy statement on Schedule 14A, which outlines proposals for its Annual General Meeting of Shareholders. The DEF 14A describes matters such as director reappointments, advisory votes on executive compensation, renewal of share issuance authorities under Irish law, and the appointment and remuneration of its statutory auditor, PricewaterhouseCoopers Ireland. It also provides information about the Board of Directors, corporate governance and compensation practices.
On Stock Titan, CMPR’s filings are updated from the SEC’s EDGAR system and paired with AI-powered summaries that highlight the main points of lengthy documents. Users can quickly understand the themes in Cimpress’ 10-K, 10-Q and 8-K filings, as well as proxy materials, without reading every page. Filings related to results of operations, governance decisions and other material events are organized in one place so investors can review Cimpress’ regulatory history and disclosures efficiently.
Cimpress plc announced that its Board of Directors has authorized a new share repurchase program for up to $200,000,000 aggregate purchase price of its issued and outstanding ordinary shares. The authorization has no expiration date and allows repurchases on the open market, through privately negotiated transactions, or via one or more self-tender offers.
This new authorization replaces the remaining unused portion of the prior repurchase authorization approved on May 29, 2024, which was terminated immediately before the new program took effect. The Board emphasized that Cimpress is not required to use the full authorized amount and that repurchases are subject to its net leverage and near-term capital allocation commentary from its January 29, 2026 earnings document and may be suspended or discontinued at any time.
Cimpress PLC ownership disclosure: The Vanguard Group amended its Schedule 13G to report zero beneficial ownership of Cimpress PLC common stock following an internal realignment effective January 12, 2026.
The filing states Vanguard's subsidiaries/business divisions will report holdings separately in reliance on SEC Release No. 34-39538; the reported position shows 0 shares (0%) and zero voting or dispositive power.
Cimpress plc CEO and Chairman Robert S. Keane reported equity award activity involving performance share units (PSUs) and ordinary shares. On February 15, 2026, PSUs were exercised or converted into ordinary shares in several blocks, including 9,578, 146, and 3,388 PSUs at a price of $0.00 per unit, reflecting automatic vesting based on performance conditions.
Corresponding ordinary share entries show Keane acquiring the same amounts of ordinary shares through derivative exercise. In a separate transaction coded F, 4,117 ordinary shares at $74.27 per share were disposed of to satisfy tax obligations related to these awards. After these transactions, Keane directly owned 74,087 ordinary shares. The filing also notes additional ordinary shares held indirectly through entities such as RHS Delaware Holdings LLC and several related LLCs and trusts.
Cimpress plc EVP & Chief Technology Officer Maarten Wensveen reported equity award vesting and related share movements. On February 15, 2026, he acquired a total of 6,860 ordinary shares through automatic vesting and conversion of restricted share units and performance share units at no exercise price.
Following these transactions, including a 2,063-share tax-withholding disposition at $74.27 per share, Wensveen directly held 28,925 Cimpress ordinary shares. The footnotes explain that each RSU and PSU represented Cimpress’ commitment to issue one ordinary share, vesting over a four-year schedule.
Cimpress plc EVP and CFO Sean Edward Quinn reported equity award activity on February 15, 2026. He acquired 2,300 ordinary shares from vested restricted share units and 6,222 ordinary shares from vested performance share units through derivative exercises at $0.00 per share. To satisfy tax obligations, 2,546 ordinary shares were disposed of at $74.27 per share. After these transactions, he directly owned 46,859 ordinary shares.
Cimpress plc executive Florian Baumgartner reported equity award vesting and related share movements. On February 15, 2026, restricted share units and performance share units automatically vested, representing Cimpress’ commitment to issue one ordinary share for each vested unit.
These awards converted into ordinary shares at no exercise price, increasing his direct holdings, including 1,691 shares from restricted share units and additional shares from performance share units based on performance conditions. On the same date, 3,106 ordinary shares at $74.27 per share were disposed of to satisfy tax withholding obligations, a non‑open‑market, tax-related transaction, leaving 63,843 ordinary shares held directly.
ArrowMark Colorado Holdings, LLC filed an amended Schedule 13G showing a passive ownership stake in Cimpress plc. ArrowMark reports beneficial ownership of 882,970 ordinary shares, representing 3.58% of Cimpress’s ordinary shares as of the 12/31/2025 event date.
The firm has sole power to vote and dispose of all 882,970 shares, with no shared voting or dispositive power. ArrowMark certifies the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Cimpress.
Cimpress plc reported that Janus Henderson Group plc, through its asset manager subsidiaries, may be deemed the beneficial owner of 3,620,423 ordinary shares of Cimpress, representing 14.7% of the class as of the event date of 12/31/2025.
All 3,620,423 shares are reported with shared voting and shared dispositive power, and none with sole power. Within these holdings, Janus Henderson Enterprise Fund beneficially owns 2,355,405 shares, equal to 9.6% of Cimpress. The shares are held in managed portfolios, which retain the rights to dividends and sale proceeds, and the filing states they are held in the ordinary course of business and not to influence control of Cimpress.
Rubric Capital Management LP and David Rosen report beneficial ownership of 1,525,000 Cimpress plc ordinary shares, representing 6.18% of the class. This percentage is based on 24,671,784 ordinary shares outstanding as of October 27, 2025, from Cimpress’s Form 10-Q.
The shares are held through Rubric-managed investment funds, including Rubric Capital Master Fund LP, which has the right to receive dividends or sale proceeds on more than 5% of the ordinary shares. The filers certify the position is held in the ordinary course of business and not for the purpose of changing or influencing control of Cimpress.
Spruce House investment entities filed Amendment No. 2 to their Schedule 13D for Cimpress plc, updating their ownership and recent activity in the stock. The group reports that The Spruce House Partnership LLC holds 1,465,366 ordinary shares, representing about 6.03% of Cimpress’s 24,285,192 shares outstanding as of January 26, 2026.
Individual managers Zachary Sternberg and Benjamin Stein each report direct personal holdings of 17,873 and 16,805 shares, respectively, which bring their total beneficial ownership to roughly 6.11% and 6.10%. The filing states that recent sales of Cimpress shares by the reporting persons were made for portfolio management purposes and notes that unvested performance stock units held by Sternberg were excluded from these ownership calculations.